SCHEME 2. Synthesis of [2′-18O]Uridine
type 5′-UG and 5′-UGGGUCGGC gave [M - H]- peaks at
m/z 588 and 2881, respectively.
In conclusion, regiochemistry of nucleophilic reactions with
2,2′-cyclouridine appears to be influenced by the chemical
context of the nucleophilic atom and the presence of acid. Using
these hypotheses as a guide, we developed reaction conditions
in which an oxygen nucleophile (potassium benzoate in the
presence of benzoic acid) favors ribose attack over nucleobase
attack by 20-fold. This regioselectivity allows for efficient
synthesis of [2′-18O]uridine and its phosphoramidite from 2,2′-
cyclouridine and [18O2]benzoic acid. This approach may also
be applied for converting the 2,3′-cyclouridine to [3′-18O]uridine.
We can now construct RNA substrates containing [2′-18O]-
uridine isotopologues, thereby enabling isotope effect analyses
of protein and RNA enzymes that catalyze 2′-O-transphospho-
rylation reactions. Through known transformations of uridine,28
we may also access [2′-18O] isotope-enriched cytidine, adenos-
ine, and guanosine.
convert 2′-O-benzoyluridine to uridine, the 1H NMR spectrum
indicated that uridine and 1-(â-D-arabinofuranosyl)uracil formed
in a 5:1 ratio.
Using 2 equiv of KOBz instead of 1 equiv had little effect
on the reaction rate or the ratio of the ribo/arabino products.
However, we found that the presence of benzoic acid accelerated
the reaction and improved regioselectivity further.24 A mixture
of BzOH (1.0 equiv) and KOBz (1.0 equiv) at 140 °C in DMF
consumes 1 completely within 48 h to give the products in a
ratio of 20:1 ribo/arabino.25 The increased reaction rate and
regioselectivity upon addition of benzoic acid may reflect acid
catalysis, in which protonation of the imino nitrogen alters the
regiochemical outcome of the reaction.
We then exploited our observations to synthesize the target
isotopomer, 2 (Scheme 2). Acidic hydrolysis of benzonitrile in
H218O gave [18O2]benzoic acid containing 80% isotope enrich-
ment (MS).6 To avoid loss of 18O, we prepared a mixture of
1:1 [18O2]benzoic acid and potassium [18O2]benzoate by treating
[18O2]benzoic acid (2.0 equiv) with potassium hydride (1.0
equiv) in DMF. After addition of 1 (1.0 equiv), the mixture
was heated to 140 °C. After 4 days, TLC showed that 1 was
almost completely consumed. After removal of DMF under high
vacuum, we treated the residue with NaOMe/MeOH to convert
2′-[18O2]benzoyluridine to [2′-18O]uridine. After column chro-
matography, we obtained 2 in 88% yield (80% isotope enrich-
ment as determined by MS). As expected, the new compound
gave essentially the same 1H and 13C NMR spectra as an
authentic sample of uridine. In addition, we observed an 18O-
induced 13C NMR shift26 of 1.54 Hz upfield for 2′-C of [2′-
18O]uridine, further confirming the position of 18O.7a
Experimental Section
[2′-18O]Uridine (2): To a pressure tube (35 mL) under argon
were added anhydrous DMF (20 mL), KH (35%, 457 mg, 4 mmol),
and [18O2]benzoic acid (1.01 g, 8 mmol, 2 equiv). After the reaction
was stirred for 10 min at rt, 2,2′-cyclouridine (904 mg, 4 mmol, 1
equiv) was added. The mixture was heated to 140 °C for 4 days.
The reaction mixture was concentrated to dryness under vacuum.
The residue was dissolved in methanol (20 mL), and sodium
methoxide in methanol (30%, 1.52 mL, 2 equiv) was added. The
mixture was stirred overnight at rt, and acetic acid (690 µL, 3 equiv)
was added. The mixture was stirred at rt for an additional 10 min
and concentrated to dryness under vacuum. The residue was purified
by silica gel chromatography, eluting with 10% methanol in ethyl
acetate, to give 2 (859 mg, 88%) as a white solid: 1H NMR (500
MHz, DMSO-d6) δ 11.30 (br, 1H), 7.88 (d, J ) 8.2 Hz, 1H), 5.78
(m, 1H), 5.65 (d, J ) 8.2 Hz, 1H), 5.36 (br, 1H), 5.07 (br, 2H),
4.01 (m, 1H), 3.95 (m, 1H), 3.83 (m, 1H), 3.60 (m, 1H), 3.55 (m,
1H); 13C NMR (125.8 Hz, DMSO-d6) δ 163.5, 151.1, 141.1, 102.1,
88.0, 85.2, 73.9, 70.2, 61.2; HRMS calcd for C9H12N2O518O, [MH+]
247.0816, found 247.0818.
Acknowledgment. Q.D. is a Research Assistant Professor
at the University of Chicago, and J.A.P. is an Investigator of
the Howard Hughes Medical Institute. We thank the following
members of the Piccirilli laboratory for critical comments on
the manuscript: C. Lea, R. Fong, T. Novak, R. Sengupta, K.
Sundaram, J. Ye, Dr. N.-S. Li, Dr. J. Lu, Y. Koldobskaya, S.
Koo, and J. Min. We also thank Dr. N.-S. Li for oligo synthesis.
We transformed [2′-18O]uridine to the corresponding phos-
phoramidite 3 using standard methods (see Supporting Informa-
tion).27 We used 3 to incorporate [2′-18O]uridine into two
oligonucleotides, [2′-18O]UG and [2′-18O]UGGGUCGGC, ac-
cording to standard RNA synthesis protocols. After deprotection
and purification by reversed-phase HPLC, MALDI-TOF MS
confirmed the masses of the oligonucleotides, giving the
expected [M - H]- peaks at m/z 590 and 2883, while the wild-
Supporting Information Available: A scheme and experimen-
1
tal details for synthesis of phosphoramidite 3; H and 13C NMR
spectra for compounds 2 and 3. This material is available free of
(24) This reactivity trend should be viewed with caution, as it is based
on a limited number of independent examples rather than systematic
investigation of factors such as solvent, pH, temperature, bases, and the
“chemical context” of the nucleophilic atom.
JO701727H
(25) In the presence of 2 equiv of BzOH (without KOBz), the reaction
produced only a trace amount of product as indicated by TLC, presumably
due to the weak nucleophilicity of benzoic acid.
(26) Risley, J. M.; Van Etten, R. L. J. Am. Chem. Soc. 1979, 101, 252.
(27) (a) Hakimelahi, G. H.; Proba, Z. A.; Ogilvie, K. K. Tetrahedron
Lett. 1981, 22, 4775. (b) Moyroud, E.; Biala, E.; Strazewski, P. Tetrahedron
2000, 56, 1475. (c) Milecki, J.; Zamaratski, E.; Maltseva, T. V.; Foldesi,
A.; Adamiak, R. W.; Chattopadhyaya, J. Tetrahedron 1999, 55, 6603.
(28) For conversion of uridine to cytidine, see: (a) Saladino, R.; Crestini,
C.; Bernini, R.; Frachey, G.; Mincione, E.; J. Chem. Soc., Perkin Trans. 1
1994, 21, 3053. For conversion of uridine to adenosine, see: (b) Trelles, J.
A.; Valino, A. L.; Runza, V.; Lewkowicz, E. S.; Iribarren, A. M., Biotechnol.
Lett. 2005, 27, 759. (c) Trelles, J. A.; Fernandez, M.; Lewkowicz, E. S.;
Iribarren, A. M.; Sinisterra, J. V.; Tetrahedron Lett. 2003, 44, 2605. For
conversion of uridine to guanosine, see: (d) Mikami, Y.; Matsumoto, S.;
Hayashi, Y.; Sato, T. Jpn. Kokai Tokkyo Koho, JP 2001269192 A, 2001.
J. Org. Chem, Vol. 73, No. 1, 2008 311